SCHEDULES

SCHEDULE 4Integrated care system: minor and consequential amendments

I1I2138National Health Service Act 2006

In Schedule 12A (pharmaceutical remuneration), in paragraph 2—

a

in the heading for “clinical commissioning groups” substitute “integrated care boards”;

b

in sub-paragraph (3), for “clinical commissioning group” substitute “integrated care board”;

c

in sub-paragraph (4), for “clinical commissioning groups” substitute “integrated care boards”;

d

in sub-paragraph (5), for “clinical commissioning group” substitute “integrated care board”;

e

in sub-paragraph (6)—

i

for “a clinical commissioning group” substitute “an integrated care board”;

ii

in paragraphs (a) and (b), for “the group”, in both places it occurs, substitute “the board”;

f

in sub-paragraph (8), for “a clinical commissioning group” substitute “an integrated care board”;

g

for sub-paragraph (9) substitute—

9

For the purposes of sections 223GC and 223M(1)(b) and paragraph 22 of Schedule 1B, any amount of which an integrated care board is notified under sub-paragraph (6) is to be treated as expenditure of the group which is attributable to the performance by it of its functions in the year in question.